DiaMedica Therapeutics
DMAC
DMAC
17 hedge funds and large institutions have $1.98M invested in DiaMedica Therapeutics in 2019 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 5 increasing their positions, 5 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
69% less capital invested
Capital invested by funds: $6.37M → $1.98M (-$4.39M)
Holders
17
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$95.9K | |
| 2 | +$31K | |
| 3 | +$28K | |
| 4 |
Commonwealth Equity Services
Waltham,
Massachusetts
|
+$27K |
| 5 |
WVP
Worth Venture Partners
Fort Lee,
New Jersey
|
+$19.3K |
Top Sellers
| 1 | -$644K | |
| 2 | -$253K | |
| 3 | -$173K | |
| 4 |
Millennium Management
New York
|
-$58.1K |
| 5 |
GPCM
Granite Point Capital Management
Boston,
Massachusetts
|
-$5.67K |